giikorea.co.kr
 È¨ | ȸ»ç¼Ò°³ | ¸ÂÃãÇü ½ÃÀåÁ¶»ç | ±¹Á¦ÄÁÆÛ·±½º | ±Û·Î¹ú ÆÄÆ®³Ê | īŻ·Î±× | E-mail Service | ¿¬¶ôó | Site Map |

Conference banner

¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ½ÃÀ庸°í¼­
Biotechnology Market Research


  Page:   1  2  3  4  5  6  7  8  9  10  Next >>

Reports

DNA ½ÃÄö½ÌÀÇ ±â¼ú, ½ÃÀå, ±â¾÷
DNA sequencing: technologies, markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
DNA ½ÃÄö½ÌÀÇ °¢Á¾ ±â¼ú¿¡ ´ëÇÑ ¹ßÀü µ¿ÇâÀ» Á¶»ç ºÐ¼®Çϰí, ±âÁ¸ ±â¼ú°ú ½Å±â¼úÀÇ °³¿ä, °¢Á¾ ¾ÖÇø®ÄÉÀ̼Ç, °ü·Ã ±â¾÷/¿¬±¸±â°üÀÇ µ¿Çâ, ½ÃÀå±Ô¸ð ºÐ¼®, ½ÃÀ强Àå¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ, °¢Á¾ Á¦¾ð µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

ºÐÀÚÁø´Ü : ±â¼ú, ½ÃÀå, ±â¾÷
Molecular Diagnostics - Technologies, Markets and Companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
ÀÇ·áȰµ¿, °øÁßÀ§»ý, ÀǾàǰ »ê¾÷, ¹ýÀÇÇÐ µî¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÏ´Â ºÐÀÚÁø´Ü ±â¼ú¿¡ ´ëÇØ Á¶»çÇϰí, °¢Á¾ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) ±â¹Ý ±â¼ú, Çü±¤µ¿¼Ò±³Àâ¹ý(FISH), ÆéŸÀ̵åÇÙ»ê(PNA), DNAÀÇ Àü±âÈ­ÇаËÃâ, ¹ÙÀÌ¿ÀĨ, ³ª³ëÅ×Å©³î·¯Áö ¹× ÇÁ·ÎÅ׿À¹Í½º ±â¼ú¿¡ °üÇÑ ºÐ¼® µîÀ» ÀüÇØµå¸³´Ï´Ù.

¼¼Æ÷Ä¡·á : ±â¼ú, ½ÃÀå, ±â¾÷
Cell Therapy - Technologies, Markets and Companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
ÀÇ·áȰµ¿¿¡ ÀÖ¾î ÀÌ¹Ì Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ´Â ¼¼Æ÷Ä¡·á ±â¼ú¿¡ ´ëÇØ Á¶»çÇϰí, â¾à¿¡¼­ ¼¼Æ÷ÀÇ ¿ªÇÒ ºÐ¼®, ¼¼Æ÷Ä¡·á ½ÃÀåÀÇ °ü·Ã ±â¾÷, Çмú±â°üÀÇ Á¤º¸ µîÀ» ÀüÇØµå¸³´Ï´Ù.

ÇÁ·ÎÅ׿À¹Í½º : ±â¼ú¡¤½ÃÀ塤±â¾÷
Proteomics - Technologies, Markets and Companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
Æ÷½ºÆ®°Ô³ð ½Ã´ëÀÇ Ã¢¾à, ºÐÀÚ Áø´Ü, ÀÇ·á Ȱµ¿¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÏ´Â ÇÁ·ÎÅ׿À¹Í½º ±â¼ú¿¡ ´ëÇØ Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

½Å°æ º¸È£ : ÀǾàǰ¡¤½ÃÀ塤±â¾÷
Neuroprotection - Drugs, Markets and Companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
¹ßÀÛÀ̳ª ½Å°æ°è ¼Õ»ó µîÀÇ ±Þ¼º Áúȯ, ½Å°æº¯¼º ÀåÇØ µîÀÇ ¸¸¼º ÁúȯÀÇ Ä¡·á¿¡ À־ ½Å°æ º¸È£ÀÇ ¿ªÇÒ¿¡ ´ëÇØ Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

°æÇÇ ¾à¹°Àü´Þ(Drug Delivery) : ±â¼ú¡¤½ÃÀ塤±â¾÷
Transdermal Drug Delivery - Technologies, Markets, and Companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
°¢Á¾ °æÇÇ ¾à¹°Àü´Þ(Drug Delievery)ÀÇ ±â¼ú°ú ½ÃÀå¿¡ °üÇÑ Á¶»ç ³»¿ëÀ» °ü·Ã ±â¾÷ Á¤º¸¿Í ÇÔ²² ÀüÇØµå¸³´Ï´Ù.

µ¿¹° »ý¸í°øÇÐ : ±â¼ú, ½ÃÀå, ±â¾÷
Animal Biotechnology - Technologies, Markets and Companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
µ¿¹° »ý¸í°øÇаú ±×°ÍÀÇ ¼öÀÇÇÐ ¹× ÀǾàǰ ºÐ¾ß¿¡ ´ëÇÑ Àû¿ë, ½ÄǰÁ¦Á¶ ºÐ¾ß¿¡ ´ëÇÑ Àû¿ë µîÀÇ µ¿ÇâÀ» Á¶»ç ºÐ¼®ÇÏ°í ±â¼ú°³¿ä, °¢Á¾ ¾ÖÇø®ÄÉÀÌ¼Ç ½ÃÀå, À±¸®¼º, °úÁ¦, ½ÃÀ强Àå ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¸ÂÃãÇü ÀÇ·á(Personalized Medicine) : °úÇÐÀû¡¤»ó¾÷Àû »óȲ
Personalized Medicine - scientific & commercial aspects
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
¾à¸® °Ô³ë¹Í½º, ¾à¸® À¯ÀüÇÐ, ¾à¸® ÇÁ·ÎÅ׿À¹Í½º ¹× ´ë»çÇп¡ ±Ù°ÅÇÑ ¸ÂÃãÇü ÀÇ·á(Personalized Medicine)ÀÇ ÃֽŠ»óȲ¿¡ ´ëÇØ Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¾ÏÀÇ ¾à¹°Àü´Þ(Drug Delivery) : ±â¼ú, ½ÃÀå, ±â¾÷
Drug Delivery in Cancer - technologies, markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
¾ÏÄ¡·á ºÐ¾ßÀÇ ¾à¹°Àü´Þ(Drug Delivery) ±â¼ú ¹× ½ÃÀå, °ü·Ã ±â¾÷ÀÇ Á¤º¸ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

RNAi(RNA °£¼·) : ±â¼ú, ½ÃÀå, ±â¾÷
RNAi - technologies, markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
RNAi¿Í ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå, ¾ÐŸ¸Ó, ¸®º¸ÀÚÀÓ, ÆéŸÀ̵åÇÙ»ê ¹× LNAÀ» ÀÌ¿ëÇÑ ±âŸ ¾ÈƼ¼¾½º ¾îÇÁ·ÎÄ¡¸¦ ºñ±³ ºÐ¼®Çϰí, °¢Á¾ RNAi ±â¼úÀÇ ÇØ¼³ ¹× °ü·Ã ±â¾÷ÀÇ Á¤º¸ µîÀ» ÀüÇØµå¸³´Ï´Ù.

À¯ÀüÀÚ Ä¡·á : ±â¼ú, ½ÃÀå, ±â¾÷
Gene Therapy - technologies, markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
À¯ÀüÀÚ Ä¡·á ±â¼ú ¹× °¢Á¾ Áúȯ ŸÀÔº° À¯ÀüÀÚ Ä¡·á µ¿Çâ, °ü·Ã ±â¾÷ÀÇ Á¤º¸ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

³ª³ë¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö : ¾ÖÇø®ÄÉÀ̼ǡ¤½ÃÀ塤±â¾÷
Nanobiotechnologies- applications, markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
³ª³ë¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿¡ °ü·ÃµÈ °¢Á¾ ±â¼ú ¹× ½Å¾à, ¾à¹°Àü´Þ(µå·¯±× µô¸®¹ö¸®, Drug Delivery), ÀÓ»ó ¾ÖÇø®ÄÉÀÌ¼Ç µî¿¡¼­ÀÇ ³ª³ë¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ÀÌ¿ë µ¿Ç⠵ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

ÁßÃ߽Űæ°è ÁúȯÀÇ ¾à¹°Àü´Þ(Drug Delivery) : ±â¼ú¡¤½ÃÀ塤±â¾÷
Drug Delivery in Central Nervous System Diseases - technologies, markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
ÁßÃ߽Űæ°è ÁúȯÀÇ ¾à¹°Àü´Þ ±â¼ú, ½ÃÀå ¹× °ü·Ã±â¾÷ Á¤º¸¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

½ÉÇ÷°üÀ¸·ÎÀÇ ¾à¹°Àü´Þ(Drug Delivery) : ±â¼ú¡¤½ÃÀ塤±â¾÷
Cardiovascular Drug Delivery - technologies,markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
½ÉÇ÷°üÀ¸·ÎÀÇ ¾à¹°Àü´Þ(Drug Delivery) ±â¼ú, ½ÃÀå ¹× °ü·Ã±â¾÷ Á¤º¸¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ÀÇ ±â¼ú, ½ÃÀå, ±â¾÷
Biomarkers - technologies,markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
´Ù¾çÇÑ Á¾·ùÀÇ ¹ÙÀÌ¿À¸¶Ä¿ °³¿ä, ¹ÙÀÌ¿À¸¶Ä¿ ¹ßÀüÀ» À§ÇÑ °¢Á¾ ±â¼ú, °¢Á¾ Áúº´ ºÐ¾ß¿¡¼­ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ¿ªÇÒ µîÀ» Á¶»ç ºÐ¼®ÇÏ°í ±ÔÁ¦»óÀÇ °úÁ¦, ¹ÌÃÑÁ· ¿ä°Ç, ½ÃÀ强Àå ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¼¼Æ÷À¯ÀüÇÐ(Cytogenetics) : ±â¼ú¡¤½ÃÀ塤±â¾÷
Cytogenetics - technologies,markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
¿°»öü ±¸Á¶ÀÇ ¼ö½Ä ¹× Áúȯ¿¡ °ü·ÃµÈ ÀÌ»óÀ» ƯÁ¤ÇÏ´Â ¼¼Æ÷À¯ÀüÇÐ(Cytogenetics)¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

Ç×¹ÙÀÌ·¯½º Ä¡·á : ±â¼ú¡¤½ÃÀ塤±â¾÷
Antiviral Therapeutics - technologies, markets and companies
  Pub Time : 2010/02
  Published by : Jain Pharmabiotech
°¢Á¾ Ç×¹ÙÀÌ·¯½º Ä¡·á ±â¼ú, ½ÃÀå µ¿Çâ, ±â¾÷ Á¤º¸ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¾Ï Áٱ⼼Æ÷ : Ä¡·á Àü·«°ú ÆÄÀÌÇÁ¶óÀÎ °³¹ß(2010³â)
Targeting Cancer Stem Cells: Therapeutic Strategies and Pipeline Developments (2010)
  Pub Time : 2010/01
  Published by : BioPharm Reports (Technology and Markets Ltd)
¾Ï Áٱ⼼Æ÷¿¡ °üÇÑ ¼¼°èÀÇ ¿¬±¸ °³¹ß Ãֽе¿ÇâÀ» Æ÷°ýÀûÀ¸·Î °ËÁõÇÏ°í ºÐ¾ß¿¡ Âü°¡ÇÏ´Â ±â¾÷ µ¿Çâ ¹× Àü·«, °úÁ¦ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

Áß±¹ÀÇ ´ÜÀÏ Å¬·Ð Ç×ü ½ÃÀå
Chinese Markets for Monoclonal Antibody
  Pub Time : 2010/01
  Published by : Asia Market Information & Development Co.
Áß±¹ÀÇ °æÁ¦ µ¿Çâ, ´ÜÀÏ Å¬·Ð Ç×ü ½ÃÀåÀÇ ÅõÀÚ È¯°æ, »ê¾÷ÀÇ ¹ßÀü, ¼ö¿ä ¹× °ø±Þ, »ê¾÷ ±¸Á¶, ½ÃÀå ä³Î ¹× ÁÖ¿ä ±â¾÷ µî¿¡ ´ëÇØ »ó¼¼È÷ Á¶»çÇϰí, 2003³â ¹× 2008³âÀÇ ½ÇÀû, 2013³â ¹× 2018³âÀÇ Àå±â ¿¹ÃøÀ» ÀüÇØµå¸³´Ï´Ù.

Áß±¹ÀÇ Ç÷¾×Á¦Á¦ ½ÃÀå
Chinese Markets for Blood Products
  Pub Time : 2010/01
  Published by : Asia Market Information & Development Co.
Áß±¹ÀÇ °æÁ¦ µ¿Çâ, Ç÷¾×Á¦Á¦ ½ÃÀåÀÇ ÅõÀÚ È¯°æ, »ê¾÷ÀÇ ¹ßÀü, ¼ö¿ä ¹× °ø±Þ, »ê¾÷ ±¸Á¶, ½ÃÀå ä³Î ¹× ÁÖ¿ä ±â¾÷ µî¿¡ ´ëÇØ »ó¼¼È÷ Á¶»çÇϰí, 2003³â ¹× 2008³âÀÇ ½ÇÀû, 2013³â ¹× 2018³âÀÇ Àå±â ¿¹ÃøÀ» ÀüÇØµå¸³´Ï´Ù.

15°³ Ä¡·á ºÐ¾ß¸¦ À§ÇÑ Á¦³×¸¯ ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÁ¦³×¸¯ ÀǾàǰ : ¹Ì±¹, À¯·´, ÀϺ» ¹× ±âŸ ½ÃÀåÀÇ µ¿Çâ°ú 2008¡­2013³â ¿¹Ãø
Generic and Biogeneric Drugs for 15 Major Therapeutic Categories: U.S./ E.U./ Japan/ ROW Market Trends and Directions 2008-2013
  Pub Time : 2010/01
  Published by : Fuji-Keizai U.S.A., Inc.
Á¦³×¸¯ ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÁ¦³×¸¯ ÀǾàǰ ½ÃÀåÀÇ µ¿Çâ°ú ±Ô¸ð¿¡ ´ëÇØ ºÐ¼®Çϰí, 2013³â±îÁöÀÇ 5°³³â ¿¹Ãø, ºÎ¹®º° µ¿Çâ, À¯·´, ÀϺ» µî Áö¿ªº° µ¿ÇâÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼Æ÷Ä¡·á¸¦ À§ÇÑ Áٱ⼼Æ÷ ½ÃÀå : 2010³â
Stem Cells for Cellular Therapy 2010 Market Report
  Pub Time : 2010/01
  Published by : Select Biosciences, Ltd.
Áٱ⼼Æ÷ ½ÃÀåÀÇ µ¿ÇâÀ» Á¤¼ºÀû, Á¤·®ÀûÀ¸·Î ºÐ¼®Çϰí, Á¦Ç°º°, Áö¿ªº° ½ÃÀå ¿¹Ãø, Á¦´ëÇ÷ ÀºÇà ½ÃÀåÀÇ °³¿ä µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸¶ÀÌÅ©·Î RNA ¿¬±¸ ½ÃÀå : 2010³â
MicroRNA Research and Disease Associations 2010 Market Report
  Pub Time : 2010/01
  Published by : Select Biosciences, Ltd.
¸¶ÀÌÅ©·Î RNA(miRNA) ¿¬±¸ ½ÃÀåÀÇ µ¿ÇâÀ» Á¤¼ºÀû, Á¤·®ÀûÀ¸·Î ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð ¹× ¼ºÀå·ü, ÇâÈÄ ¿¹Ãø, ½ÃÀå ºÎ¹®º° µ¿Çâ, ½ÃÀåÀÇ ±âȸ, ¹ÌÃæÁ· ¿ä±¸¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

Á¦´ëÇ÷ ¾÷°èÀÇ ¼ºÀå±âȸ
Capitalizing on Opportunities in Cord Blood Industry Growth
  Pub Time : 2010/01
  Published by : BioInformant
Á¦´ëÇ÷ ÀºÇà ¾÷°èÀÇ °ú°Å 12°³¿ù°£ ½ÇÀû°ú ½Å±Ô Âü°¡ µ¿Çâ, ¾÷°è Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ, ±¹°¡º° ºñ¿ë ºÐ¼® µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå : ¸¶ÀÌÅ©·Î¾î·¹ÀÌ¿Í ·¦¿Â¾îĨ(Lab-on-a-Chip)
Global Biochip Markets: Microarrays and Lab-on-a-Chip
  Pub Time : 2010/01
  Published by : BCC Research
¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ¾÷°è¸¦ Á¶»ç ºÐ¼®Çϰí, ÇöÀç ¹× ÇâÈÄ¿¡ ÀÌ¿ëµÇ´Â ´Ù¾çÇÑ ¹ÙÀÌ¿ÀĨÀÇ ¿ëµµ, ½ÃÀåÀÇ ÇöȲ°ú 2014³â±îÁöÀÇ È®´ë ¿¹Ãø, Ãֽбâ¼ú µ¿Çâ, ¾÷°è¿¡ Âü°¡ÇÏ´Â ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö Àåºñ ½ÃÀå
The Global Market for Equipment Used in Biotechnology Applications
  Pub Time : 2010/01
  Published by : BCC Research
¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö Àåºñ ½ÃÀå¿¡ ´ëÇÑ 2007³â°ú 2008³âÀÇ ½ÇÀûÀ» Á¤¸®Çϰí, 2009³âºÎÅÍ 2014³â±îÁöÀÇ ¿¹Ãø°ú ¼ºÀå·ü, ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀϰú ƯÇã µ¿ÇâÀ» ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

´ÙÁߺм®(Multiplex Assays) : ¹ßÀüÇÏ´Â ±â¼ú, ÀÀ¿ë, ÇâÈÄÀÇ ¹æÇ⼺
Multiplex Assays: Evolving Technologies, Applications and Future Directions
  Pub Time : 2010/01
  Published by : Insight Pharma Reports
´ÙÁߺм®(Multiplex Assays) ºÐ¾ßÀÇ ÃÖ±Ù ¹ßÀü µ¿Çâ¿¡ ÃÊÁ¡À» ¸ÂÃß¾î µ¿ ±â¼úÀÇ ´Ù¾çÇÑ ºÐ¾ß¿¡ÀÇ ÀÀ¿ë µ¿Çâ, ÇâÈÄÀÇ ¹ßÀü Àü¸Á µîÀ» ÀüÇØµå¸³´Ï´Ù.

À¯ÀüÀÚÄ¡·á : 20³âÀÇ ÀÓ»ó°³¹ß
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
  Pub Time : 2009/12
  Published by : Datamonitor
ÇöÀçÀÇ À¯ÀüÀÚÄ¡·á °³¹ß ÆÄÀÌÇÁ¶óÀÎÀ» »ó¼¼È÷ ºÐ¼®ÇßÀ¸¸ç, ÁÖ¿ä ÀûÀÀÇ¥Àû°ú º» ºÐ¾ß¿¡¼­ Ȱ¾àÇÏ´Â ±â¾÷À» ¼Ò°³Çϸ鼭 ±â¼ú µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

·ù¸ÓƼÁò¿¡¼­ÀÇ ¹ÙÀÌ¿À¸¶Ä¿ : ¸ÂÃãÇü ÀÇ·á(Personalized Medicine)¸¦ ÇâÇÑ ´ÙÀ½ ´Ü°è
Stakeholder Opinions: Biomarkers in Rheumatology - Awaiting the next step towards personalized medicine
  Pub Time : 2009/12
  Published by : Datamonitor
5°¡Áö ·ù¸ÓƼÁò Áúȯ¿¡ ÀÌ¿ëµÇ´Â ¹ÙÀÌ¿À¸¶Ä¿ÀÇ Á¾·ù¿Í °³¿ä, ÇâÈÄ À¯¸Á½ÃµÇ´Â ¹ÙÀÌ¿À¸¶Ä¿, ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸ °³¹ß¿¡ Âü°¡ÇÏ´Â ±â¾÷ÀÇ °³¿ä¿Í Ãֽе¥ÀÌÅÍ¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¸ÂÃãÇü ÀÇ·áÀÇ ¹Ì·¡»ó
Business Strategy: Personalized Medicine Looking Forward
  Pub Time : 2009/12
  Published by : Health Industry Insights
¸ÂÃãÇü ÀÇ·áÀÇ ÇöÀç »óȲÀ» ¼³¸íÇϰí ÀÇ·á¾÷°è¿¡ °üÇÑ ´Ù¾çÇÑ ±â¾÷¿¡ ¹ÌÄ¡´Â ¿µÇâ µîÀ» ºÐ¼®ÇÏ¿© ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎ ¹× ÇâÈÄ ¹ßÀü ´Ü°è, ÁÖ¿ä ¼ºÀå ºÐ¾ß µîÀ» ÇØ¸íÇÏ°í °¢Á¾ ÀÇ·á °ü·Ã ±â¾÷¿¡ ´ëÇÑ Á¦¾ð µîÀ» ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿À ÇÃ¶ó½ºÆ½ ½ÃÀå
Global Bio-based Plastics Market
  Pub Time : 2009/12
  Published by : Frost & Sullivan
¼¼°èÀÇ ¹ÙÀÌ¿À ÇÃ¶ó½ºÆ½ ½ÃÀåÀ» Ãë±ÞÇϸç, ÁÖ¿ä µ¿Çâ, ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀΰú ÀúÇØ¿äÀÎ, Àå·¡¼º µîÀ» ºÐ¼®ÇßÀ¸¸ç °¢Á¾ Á¦Ç°ÀÇ ½ÃÀå¿¡ ´ëÇØ¼­µµ »ó¼¼È÷ °ËÅäÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ µ¿¹Ý Áø´Ü ½ÃÀå
U.S. Companion Diagnostics Markets
  Pub Time : 2009/12
  Published by : Frost & Sullivan
¹Ì±¹ÀÇ µ¿¹Ý Áø´Ü ½ÃÀå¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ªÀÇ Ä¡°ú¿ë °ñÀÌ½ÄÆí ´ëü¹°¤ý±âŸ »ýü ÀûÀÀ Àç·á ½ÃÀå : 2009³â(ÀϺ»¤ýÇѱ¹¤ý¿À½ºÆ®·¹Àϸ®¾Æ)
Asia Pacific Markets for Dental Bone Graft Substitutes and Other Biomaterials 2009 (Japan, South Korea, Australia)
  Pub Time : 2009/12
  Published by : iData Research Inc.
¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ªÀÇ Ä¡°ú¿ë °ñÀÌ½ÄÆí ´ëü¹°¤ý±âŸ »ýü ÀûÀÀ Àç·á ½ÃÀå Àüü¿Í ÀϺ», Çѱ¹, ¿À½ºÆ®·¹Àϸ®¾Æ¸¦ ±¹°¡º°·Î Á¶»ç ºÐ¼®ÇÏ°í ½ÃÀå ¿¹Ãø, ½ÃÀå ¼ºÀå ÃËÁøÀÎÀÚ/ÀúÇØÀÎÀÚ, ½ÃÀå ±â¾÷ÀÇ Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

Á¦¾à ºÎ¹®¿ë ±â¼ú ½ÃÀåÀÇ µ¿Çâ : 2010³â
2010 Trends to Watch: Pharmaceutical Technology
  Pub Time : 2009/12
  Published by : Datamonitor
Á¦¾à ºÎ¹®ÀÇ ÁÖ¿ä º¯È­¸¦ Á¶»çÇϰí, ÃÖ´ëÀÇ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î º¸ÀÌ´Â µ¿Çâ, ÀÌ·¯ÇÑ ¹ßÀüÀÌ Á¦¾àȸ»ç¿Í ±â¼ú/¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ ½Ö¹æ¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú ±âȸ¿¡ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ¹Ì·¡ : 2015³â±îÁöÀÇ ½ÃÀå ¿¹Ãø, ±âȸ ºÐ¼® ¹× ±ÔÁ¦ µ¿Çâ
The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
  Pub Time : 2009/12
  Published by : GBI Research
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå¿¡ ´ëÇØ ¼³¸íÇÏ°í ¹Ì±¹, À¯·´, ÀϺ» ½ÃÀåÀÇ µ¿Çâ, Á¦³×¸¯ ÀǾàǰ°úÀÇ °æÇÕ, ±ÔÁ¦ µ¿Çâ ¹× ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ÀüÇØµå¸³´Ï´Ù.

Drug Discovery¿¡¼­ÀÇ DNA ½ÃÄö½Ì : ¾ÖÇø®ÄÉÀ̼ǡ¤Åø¡¤¼­ºñ½º ½ÃÀå Àü¸Á ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ(40»ç)
DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles
  Pub Time : 2009/12
  Published by : Business Insights
DNA ½ÃÄö½Ì ±â¼úÀÇ ¹ßÀü µ¿Çâ°ú ½ÃÀå Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, DNA ½ÃÄö½ÌÀÇ ¹ßÀü °æÀ§, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ÀúÇØ¿äÀÎ, Åø, ¼­ºñ½º, ¾ÖÇø®ÄÉÀ̼Ç, Áö¿ª µî °¢Á¾ ¿ä¼Òº° ½ÃÀå ¼ºÀå ¿¹Ãø(¡­2014³â), ½ÅÁ¦Ç°¡¤½Å±â¼ú¡¤½Å¼­ºñ½ºÀÇ ÅõÀÔ µ¿Çâ, ÁÖ¿ä Æ¯Çã µ¥ÀÌÅÍ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

À¯ÀüÀÚ ÀçÁ¶ÇÕ Ä¡·á ¹× À¯ÀüÀÚ Á¶ÀÛ Ä¡·á
Recombinant and Designer Therapeutics
  Pub Time : 2009/12
  Published by : Technical Insights, Inc.
À¯ÀüÀÚ ÀçÁ¶ÇÕ Ä¡·á ¹× À¯ÀüÀÚ Á¶ÀÛ Ä¡·áÀÇ Ãֽе¿ÇâÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ Point of Care(POC) ½ÃÀå
Point of Care Diagnostics
  Pub Time : 2009/12
  Published by : BCC Research
¼¼°è Point of Care(POC) ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °Ë»ç À¯Çü¡¤Áö¿ªº° ½ÃÀå ¼ºÀå ¿¹Ãø(¡­2014³â), ÁÖ¿ä Á¦Á¶¾÷ÀÚÀÇ ½ÃÀå Á¡À¯À², °¢Á¾ ½ÃÀå ¿µÇâ¿äÀÎ, Ãâ½Ã Á¦Ç°ÀÇ °³¿ä, ÀÌ¿ë ±â¼ú, ÁÖ¿ä Âü°¡±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¾Ï°Ë»ç¿¡¼­ÀÇ ºÐÀÚÁø´Ü
Molecular Diagnostics in Cancer Testing
  Pub Time : 2009/12
  Published by : Trimark Publications
ºÐÀÚÁø´ÜÀ¸·Î ¾Ë·ÁÁø ü¿Ü Áø´Ü ºÐ¾ß¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®ÇÏ°í ¾ÏÀÇ °Ë»ç ¹× Ä¡·á¿¡ ¾²ÀÌ´Â ºÐÀÚÁø´Ü ½ÃÀåÀÇ ±Ô¸ð ¹× ¼ºÀå µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¾Ï¿¡ ´ëÇÑ ¾ÆÆ÷Åä½Ã½º(Apotosis) Ä¡·á : »óǰȭ µ¿Çâ
Apoptotic Therapeutics in Oncology - Where to Commercialize?
  Pub Time : 2009/11
  Published by : BioSeeker Group AB
171°³ ¾ÆÆ÷Åä½Ã½º(Apotosis) ¾àÁ¦ÀÇ °³¹ß Àü·«¿¡ ´ëÇØ ºÐ¼®Çϰí, Á¦¾àȸ»çÀÇ Æ÷Æ®Æú¸®¿À °èȹ°ú ½ÅÁ¦Ç° °³¹ß °èȹÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå : µ¿Çâ°ú ±âȸ
Biochips - A Global Update of Market Trends & Opportunities
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
¼¼°è ¹ÙÀÌ¿ÀĨ »ê¾÷ÀÇ °³¿ä, Á¦Ç°/¾ÖÇø®ÄÉÀ̼Ç, °¢±¹ ½ÃÀåÀÇ µ¿Çâ µîÀ» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

ÇÁ·ÎÅ׿À¹Í½º : ¼¼°è ½ÃÀåÀÇ µ¿Çâ
Proteomics - International Market Trends
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
ÇÁ·ÎÅ׿À¹Í½ºÀÇ °³¿ä¿Í ¼¼°è ½ÃÀå µ¿Çâ, ±â¼ú °³¹ß°ú ÀÀ¿ë ºÐ¾ß, ÃÖ±ÙÀÇ ¾÷°è µ¿Çâ, ¼¼°èÀÇ Áö¿ªº° ½ÃÀå µ¿Çâ, Âü°¡ ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ½ÃÀå
Bioinformatics - A Global Market Intelligence Report
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
¼¼°è ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ½ÃÀåÀÇ Áö¿ª/±¹°¡º° ½ÃÀå °³¿ä¿Í ¿¹Ãø, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ÀüÇØµå¸³´Ï´Ù.

۶ö ±â¼ú : ¼¼°èÀÇ ±â¼ú/½ÃÀå µ¿Çâ
Chiral Technology - International Technology & Market Trends
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
¼¼°èÀÇ Å°¶ö ±â¼ú ½ÃÀå °³¿ä ¹× ¹ßÀü µ¿Çâ, ±ÔÁ¦ ȯ°æ µî¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀϰú ÇÔ²² ÀüÇØµå¸³´Ï´Ù.

Äݶó°Õ ¹× È÷¾Ë·ç·Ð»ê ±â¹Ý »ýüÀûÀÀÀç·á : ¼¼°èÀÇ µ¿Çâ
Collagen and HA-based Biomaterials - Global Trends
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
Äݶó°Õ ¹× È÷¾Ë·ç·Ð»ê ±â¹Ý »ýüÀûÀÀÀç·á ½ÃÀåÀÇ µ¿Çâ¿¡ ´ëÇØ ºÐ¼®Çϰí, »ýüÀûÀÀÀç·áÀÇ ¿¬±¸ °³¹ß µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏ, °¢±¹ ½ÃÀ庰 µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¼ºÀåÀÎÀÚ(Ç÷¾× ¹× Á¶Á÷) ½ÃÀå
Growth Factors (Blood And Tissue) - A World Report
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
¼¼°èÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ±× ¿ªÇÒ°ú ÀÀ¿ë ºÐ¾ß, ÇâÈÄÀÇ °³¹ß µ¿Çâ, ¾÷°è ³»ÀÇ °æÇÕ µ¿Çâ, °¢±¹ ½ÃÀ庰 µ¿ÇâÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ Å°³ª¾ÆÁ¦ ÀúÇØÁ¦ ½ÃÀå
Kinase Inhibitors: Global Markets
  Pub Time : 2009/11
  Published by : BCC Research
¼¼°è Ű³ª¾ÆÁ¦ ÀúÇØÁ¦ ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, Á¦Ç° À¯Çü¡¤Àû¿ë Áúº´ ±¸ºÐº° ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¡­2014³â), ½ÃÆÇ Á¦Ç°°ú °³¹ßÁßÀÎ Á¦Ç°ÀÇ °³¿ä, ÁÖ¿ä ±â¾÷°ú ½ÃÀå Á¡À¯À², ±¹Á¦Àû Àü¸Á, ÇâÈÄÀÇ ¹æÇ⼺ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

³ó¾÷¿¡¼­ÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö : ¼¼°è ½ÃÀå µ¿Çâ
Agricultural Biotechnology - Global Market Trends
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
³ó¾÷¿¡¼­ÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿¡ ´ëÇØ ºÐ¼®Çϰí À¯ÀüÀÚ º¯Çü ÀÛ¹°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀǽÄ, ½ÃÀåÀÇ µ¿Çâ°ú ÇâÈÄ ¿¹Ãø, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö°¡ »çȸ °æÁ¦¿Í À±¸®, ȯ°æ, Àΰ£¿¡°Ô ¹ÌÄ¡´Â ¿µÇâ, ±ÔÁ¦ µ¿Çâ, °¢±¹ ½ÃÀåÀÇ µ¿Çâ¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ÀÚµ¿¡¤½Å¼Ó ¹Ì»ý¹° °Ë»ç ½ÃÀå
Automated and Rapid Microbiological Tests - A Worldwide Market Review
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
¼¼°è ÀÚµ¿¡¤½Å¼Ó ¹Ì»ý¹° °Ë»ç ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±¸Á¶, °¢Á¾ ½ÃÀå ¿µÇâ¿äÀÎ, ÁÖ¿ä Á¦Ç°ÀÇ °³¿ä(¾ÖÇø®ÄÉÀÌ¼Ç À¯Çüº°), ÁÖ¿ä ±â¾÷ÀÇ ´ëó, ¼¼°è ¹× ÁÖ¿ä ±¹°¡ ½ÃÀåÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¡­2015³â), ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ »ýüÀûÇÕ¼º Àç·á ½ÃÀå
Biocompatible Materials - A Global Market Trajectory
  Pub Time : 2009/11
  Published by : BizAcumen, Inc.
¼¼°è »ýüÀûÇÕ¼º Àç·á ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, Àç·á ±¸ºÐ °³¿ä, Á¦Ç° µ¿Çâ, R&D »óȲ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ, ¼¼°è ¹× ÁÖ¿ä ±¹°¡ ½ÃÀåÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¡­2015³â), ±ÔÁ¦ ȯ°æ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

  Page:   1  2  3  4  5  6  7  8  9  10  Next >>


| Home | Contact | E-mailing | About GII | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§| Site Map |
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç
Tel:02-2025-2992, Fax:02-2025-2993, E-mail :
(C) Copyright 2009, Global Information, Inc. All rights reserved.